1.
A Quantitative Assay for Ca2+ Uptake through Normal and Pathologic..
[2626]
|
2.
Design and Characterization of a Human Monoclonal Antibody that Mo..
[2133]
|
3.
Nuclear Morphological Remodeling in Human Granulocytes Is Linked t..
[1452]
|
4.
Cues to Opening Mechanisms From in Silico Electric Field Excitatio..
[1428]
|
5.
Selection of an ASIC1a-blocking combinatorial antibody that protec..
[1193]
|
6.
Synthesis of N-acyl sulfamates from fluorosulfonates and potassium..
[1193]
|
7.
A Human-Derived Monoclonal Antibody Targeting Extracellular Connex..
[1117]
|
8.
Connexin Hemichannel Activation by S-Nitrosoglutathione Synergizes..
[1114]
|
9.
Functionality-Independent DNA Encoding of Complex Natural Products
[1086]
|
10.
Rapid and sensitive detection of COVID-19 using CRISPR/Cas12a-base..
[1063]
|
11.
DNA-Encoded Libraries: Aryl Fluorosulfonates as Versatile Electrop..
[1005]
|
12.
Critical role of spectrin in hearing development and deafness
[872]
|
13.
A Small Molecule Selected from a DNA-Encoded Library of Natural Pr..
[865]
|
14.
Postsynaptic Targeting and Mobility of Membrane Surface-Localized ..
[823]
|
15.
MeCas12a, a Highly Sensitive and Specific System for COVID-19 Dete..
[816]
|
16.
Iridium-catalyzed C-H amidation of s-tetrazines (vol 59, pg 1149, ..
[797]
|
17.
Rapid Assessment of Binding Affinity of SARS-COV-2 Spike Protein t..
[792]
|
18.
Selection of a picomolar antibody that targets CXCR2-mediated neut..
[754]
|
19.
In Silico Maturation of a Nanomolar Antibody against the Human CXC..
[750]
|
20.
Detection of the SARS-CoV-2 D614G mutation using engineered Cas12a..
[748]
|
21.
Selenylation Chemistry Suitable for On-Plate Parallel and On-DNA L..
[739]
|
22.
Somatic MIWI2 Hinders Direct Lineage Reprogramming From Fibroblast..
[711]
|
23.
Avidity-Based Selection of Tissue-Specific CAR-T Cells from a Comb..
[685]
|
24.
CAR-T Therapy in Clinical Practice: Technical Advances and Current..
[661]
|
25.
Allosteric inhibition of CRISPR-Cas9 by bacteriophage-derived pept..
[656]
|
26.
Potent NTD-Targeting Neutralizing Antibodies against SARS-CoV-2 Se..
[654]
|
27.
A Chemistry for Incorporation of Selenium into DNA-Encoded Librari..
[647]
|
28.
A cell-cell interaction format for selection of high-affinity anti..
[638]
|
29.
Enolate-Azide [3+2]-Cycloaddition Reaction Suitable for DNA-Encode..
[620]
|
30.
Neutralizing Antibodies to SARS-CoV-2 Selected from a Human Antibo..
[612]
|
31.
Metal-Free and Open-Air Arylation Reactions of Diaryliodonium Salt..
[601]
|
32.
Converting stem cells to dendritic cells by agonist antibodies fro..
[596]
|
33.
ANTIBODY TO LEPTIN RECEPTOR
[594]
|
34.
抗SARS-CoV-2刺突蛋白的三聚体抗体
[586]
|
35.
Selection of a Full Agonist Combinatorial Antibody that Rescues Le..
[583]
|
36.
Sulfur [18F]/[19F]fluoride exchange of aryl fluorosulfate: Click c..
[568]
|
37.
Antibody gene transfer treatment drastically improves epidermal pa..
[562]
|
38.
针对SARS-CoV-2刺突蛋白的三聚体抗体
[556]
|
39.
亲和力成熟的抗ASIC1a抗体
[556]
|
40.
A potent antagonist antibody targeting connexin hemichannels allev..
[544]
|
41.
特异性抑制连接蛋白26的全人源抗体
[543]
|
42.
A DNA-encoded library for the identification of natural product bi..
[540]
|
43.
Selection of Small Molecules that Bind to and Activate the Insulin..
[539]
|
44.
ASIC1通道拮抗剂抗体
[534]
|
45.
Palladium-catalyzed one-pot phosphorylation of phenols mediated by..
[529]
|
46.
Selection of Leptin Surrogates by a General Phenotypic Screening M..
[528]
|
47.
Neutralizing antibodies targeting SARS-CoV-2 spike protein
[507]
|
48.
一种诱导蛋白质降解的多肽及其应用
[501]
|
49.
Metal-Catalyzed One-Pot On-DNA Syntheses of Diarylmethane and Thio..
[496]
|
50.
Micropillar-based phenotypic screening platform uncovers involveme..
[488]
|
51.
gem-Difluoromethylene Alkyne-Enabled Diverse C-H Functionalization..
[473]
|
52.
ANTI-CXCR2 ANTIBODIES AND USES THEREOF
[470]
|
53.
抗CXCR2抗体及其应用
[467]
|
54.
CAS蛋白抑制剂的组合物及应用
[466]
|
55.
Iridium-catalyzed C-H amidation of s-tetrazines
[465]
|
56.
Commercially derived versatile optical architecture for two-photon..
[461]
|
57.
Clickable Selenylation - a Paradigm for Seleno-Medicinal Chemistry
[457]
|
58.
DNA-Encoded Libraries: Hydrazide as a Pluripotent Precursor for On..
[450]
|
59.
ASIC1通道拮抗剂抗体
[448]
|
60.
组合抗体库技术的研究进展
[446]
|
61.
COMPOSITION AND USE OF CAS PROTEIN INHIBITORS
[446]
|
62.
The role of Acid-sensing ion channel 1a in a mouse model of ischem..
[440]
|
63.
Sulfur [18F]Fluoride Exchange Click Chemistry Enabled Ultrafast La..
[437]
|
64.
Zaire型埃博拉病毒检测抗体及其制备方法及应用
[436]
|
65.
一种Zaire型埃博拉病毒检测抗体及其制备方法及应用
[436]
|
66.
抗瘦素受体的抗体
[425]
|
67.
PRIME EDITING TOOL, FUSION RNA, AND USE THEREOF
[418]
|
68.
COMPOSITION AND USE OF CAS PROTEIN INHIBITORS
[417]
|
69.
COMPOSITION AND USE OF CAS PROTEIN INHIBITORS
[416]
|
70.
一种抗新冠病毒的抗体及其制备方法和应用
[413]
|
71.
亲和力成熟的抗ASIC1a抗体
[409]
|
72.
一种特异性抑制连接蛋白26的全人抗体
[406]
|
73.
一种特异性抑制酸敏感离子通道I型的全人抗体
[395]
|
74.
特异性抑制连接蛋白26的全人抗体
[381]
|
75.
Antibody to leptin receptor
[380]
|
76.
有机化合物功能性独立的标记
[378]
|
77.
ASIC1通道拮抗剂抗体
[378]
|
78.
鬼臼毒素在激活BMP信号通路中的用途
[375]
|
79.
一种含磺酰氟的对PARP受体具有高亲和力的化合物及其制备和用途
[374]
|
80.
用于治疗CLOUSTON型外胚层发育不良2的组合物和方法
[362]
|
81.
瘦素受体抗体
[357]
|
82.
Anti-CXCR2 antibodies and uses thereof
[354]
|
83.
SULFONYL FLUORIDE-CONTAINING COMPOUND WITH HIGH AFFINITY TO PARP R..
[350]
|
84.
治疗外胚层发育不良2型,Clouston型的组合物和方法
[339]
|
85.
FULLY HUMAN ANTIBODY SPECIFICALLY INHIBITING CONNEXIN 26
[338]
|
86.
Cas蛋白抑制剂的组合物及应用
[336]
|
87.
FUNCTIONALITY INDEPENDENT LABELING OF ORGANIC COMPOUNDS
[335]
|
88.
AFFINITY-MATURATED ANTI-ASIC1a ANTIBODIES
[334]
|
89.
特异性抑制连接蛋白26的全人抗体
[331]
|
90.
Connexin 26 specific inhibition of fully human antibodies
[329]
|
91.
FUNCTIONALITY INDEPENDENT LABELING OF ORGANIC COMPOUNDS
[324]
|
92.
ASIC1通道拮抗剂抗体
[323]
|
93.
ANTIBODIES AGAINST SARS-COV-2 SPIKE PROTEIN
[320]
|
94.
ASIC1 channel antagonist antibody
[319]
|
95.
Affinity-maturated anti-ASIC1a antibodies
[318]
|
96.
治疗外胚层发育不良2型,Clouston型的组合物和方法
[317]
|
97.
瘦素受体抗体
[312]
|
98.
瘦素受体抗体
[311]
|
99.
ASICI通道拮抗剂抗体
[301]
|
100.
治疗外胚层发育不良2型,Clouston型的组合物和方法
[296]
|